Antibiotice S.A. (BVB:ATB)
2.480
0.00 (0.00%)
At close: Oct 30, 2025
Antibiotice Revenue
Antibiotice had revenue of 175.80M RON in the quarter ending June 30, 2025, with 1.82% growth. This brings the company's revenue in the last twelve months to 669.82M, up 2.94% year-over-year. In the year 2024, Antibiotice had annual revenue of 688.70M with 11.93% growth.
Revenue (ttm)
669.82M
Revenue Growth
+2.94%
P/S Ratio
2.49
Revenue / Employee
493.97K
Employees
1,357
Market Cap
1.67B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 688.70M | 73.41M | 11.93% |
| Dec 31, 2023 | 615.29M | 110.29M | 21.84% |
| Dec 31, 2022 | 505.00M | 126.17M | 33.31% |
| Dec 31, 2021 | 378.83M | 31.60M | 9.10% |
| Dec 31, 2020 | 347.22M | -47.92M | -12.13% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| OMV Petrom | 34.89B |
| Digi Communications | 12.81B |
| Societatea Energetica Electrica | 11.69B |
| Banca Transilvania | 9.93B |
| S.P.E.E.H. Hidroelectrica | 8.35B |
| SNGN Romgaz | 8.28B |
| CNTEE Transelectrica | 6.14B |
| S.N. Nuclearelectrica | 5.49B |